Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nami Yamashita

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|July 28, 2022
Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer ProgressionNami Yamashita, Donald Kufe
Digestive Surgery|June 26, 2008
Bowel obstruction due to sciatic herniaMasanori Tokunaga, Ken Shirabe, Nami Yamashita, et al.
Surgery Today|November 13, 2013
Luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancerKimihiro Tanaka, Eriko Tokunaga, Nami Yamashita, et al.
Breast Cancer (Tokyo, Japan)|November 23, 2023
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancerAsumi Iesato, Atsushi Fushimi, Rie Tahara, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 13, 2019
Cardioprotective effect of renin-angiotensin inhibitors and β-blockers in trastuzumab-related cardiotoxicityKisho Ohtani, Tomomi Ide, Ken-Ichi Hiasa, et al.
Anticancer Research|March 31, 2018
The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast CancerYuka Inoue, Nami Yamashita, Hiroki Ueo, et al.
Cancer Science|August 27, 2014
Molecular mechanisms regulating the hormone sensitivity of breast cancerEriko Tokunaga, Yuichi Hisamatsu, Kimihiro Tanaka, et al.
Breast Cancer (Tokyo, Japan)|November 11, 2010
High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancersEriko Tokunaga, Satoko Okada, Nami Yamashita, et al.
Human Pathology|May 4, 2016
Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breastKatsumi Takizawa, Hidetaka Yamamoto, Kenichi Taguchi, et al.
Clinical Breast Cancer|March 13, 2018
Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast CancerNami Yamashita, Eriko Tokunaga, Makoto Iimori, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|July 28, 2022
Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer ProgressionNami Yamashita, Donald Kufe
Digestive Surgery|June 26, 2008
Bowel obstruction due to sciatic herniaMasanori Tokunaga, Ken Shirabe, Nami Yamashita, et al.
Surgery Today|November 13, 2013
Luteinizing hormone-releasing hormone agonist plus an aromatase inhibitor as second-line endocrine therapy in premenopausal females with hormone receptor-positive metastatic breast cancerKimihiro Tanaka, Eriko Tokunaga, Nami Yamashita, et al.
Breast Cancer (Tokyo, Japan)|November 23, 2023
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancerAsumi Iesato, Atsushi Fushimi, Rie Tahara, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 13, 2019
Cardioprotective effect of renin-angiotensin inhibitors and β-blockers in trastuzumab-related cardiotoxicityKisho Ohtani, Tomomi Ide, Ken-Ichi Hiasa, et al.
Anticancer Research|March 31, 2018
The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast CancerYuka Inoue, Nami Yamashita, Hiroki Ueo, et al.
Cancer Science|August 27, 2014
Molecular mechanisms regulating the hormone sensitivity of breast cancerEriko Tokunaga, Yuichi Hisamatsu, Kimihiro Tanaka, et al.
Breast Cancer (Tokyo, Japan)|November 11, 2010
High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancersEriko Tokunaga, Satoko Okada, Nami Yamashita, et al.
Human Pathology|May 4, 2016
Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breastKatsumi Takizawa, Hidetaka Yamamoto, Kenichi Taguchi, et al.
Clinical Breast Cancer|March 13, 2018
Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast CancerNami Yamashita, Eriko Tokunaga, Makoto Iimori, et al.
Pageof 8